What is the appropriate dose of levofloxacin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Levofloxacin Dosing

The standard adult dose of levofloxacin is 500-750 mg once daily, with specific dosing determined by the indication and severity of infection. 1

Adult Dosing by Indication

Standard Dosing (Normal Renal Function)

The FDA-approved dosing for levofloxacin varies by indication 1:

  • Community-acquired pneumonia: 750 mg once daily for 5 days (high-dose short course) OR 500 mg once daily for 7-14 days
  • Acute pyelonephritis/complicated UTI: 750 mg once daily for 5 days OR 250 mg once daily for 10 days 2
  • Uncomplicated UTI: 250 mg once daily for 3 days
  • Drug-resistant tuberculosis: 500-1,000 mg daily 3

High-Dose Regimens

For severe infections or drug-resistant organisms, higher doses may be warranted:

  • MDR-TB treatment: Up to 1,500 mg daily (approximately 25 mg/kg) has been identified as optimal for achieving therapeutic targets 4
  • Severe pneumonia: 750 mg once daily maximizes concentration-dependent killing and reduces resistance development 5

Pediatric Dosing

For children 6 months to 17 years, levofloxacin dosing is weight-based and age-stratified 6:

  • Ages 6 months to 5 years: 16-20 mg/kg/day divided every 12 hours (maximum 750 mg/day)
  • Ages 5-16 years: 8-10 mg/kg once daily (maximum 750 mg/day)

Important caveat: Long-term fluoroquinolone use in children is not FDA-approved due to concerns about cartilage/bone effects, but experts agree it should be considered for MDR-TB in children when no alternatives exist 3.

For MDR-TB prevention in children, recent modeling suggests 7:

  • Dispersible 100 mg tablets: 8-33 mg/kg using weight bands
  • Solid 250 mg tablets: 10-42 mg/kg using weight bands

Renal Dose Adjustment

Levofloxacin requires dose adjustment when creatinine clearance falls below 50 mL/min because 80% is renally cleared 3, 1:

  • CrCl 20-49 mL/min: 750 mg initial dose, then 750 mg every 48 hours OR 500 mg initial dose, then 250 mg every 24 hours
  • CrCl 10-19 mL/min: 750 mg initial dose, then 500 mg every 48 hours OR 500 mg initial dose, then 250 mg every 48 hours
  • Hemodialysis: 750-1,000 mg three times weekly; no supplemental dose needed post-dialysis 3

Critical Administration Considerations

Drug Interactions

Levofloxacin must be separated from divalent/trivalent cations by at least 2 hours 3, 1:

  • Antacids containing magnesium or aluminum
  • Iron supplements
  • Multivitamins with zinc
  • Sucralfate
  • Didanosine buffered formulations

These agents markedly decrease fluoroquinolone absorption through chelation.

Hepatic Impairment

No dose adjustment needed—levofloxacin undergoes minimal hepatic metabolism (<5%) 3, 1.

Pregnancy

Avoid in pregnancy due to teratogenic effects demonstrated in animal studies 3.

Practical Dosing Algorithm

  1. Determine indication and severity

    • Mild-moderate infection: 500 mg daily
    • Severe infection or resistant organism: 750 mg daily
    • MDR-TB: 750-1,000 mg daily (consider up to 1,500 mg for optimal outcomes)
  2. Assess renal function

    • CrCl ≥50 mL/min: Standard dosing
    • CrCl <50 mL/min: Reduce frequency or dose per table above
  3. Check for interacting medications

    • Separate from cation-containing products by 2+ hours
  4. Duration

    • Short-course high-dose (750 mg × 5 days) for CAP, pyelonephritis
    • Standard course (500 mg × 7-14 days) for most infections
    • Extended therapy (months) for MDR-TB

The high-dose, short-course regimen (750 mg × 5 days) offers advantages of improved compliance, maximized concentration-dependent killing, and reduced resistance selection while maintaining equivalent efficacy to longer standard-dose regimens 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.